📞 
— free, 24/7
— free, 24/7 — free, 24/7| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 100/50mcg | 3 inhalers | £122.45 | £408.16 £367.34 Best Price | |
| 100/50mcg | 2 inhalers | £126.94 | £282.09 £253.88 | |
| 100/50mcg | inhaler | £151.65 | £168.50 £151.65 | |
| 250/50mcg | 3 inhalers | £131.81 | £439.36 £395.43 | |
| 250/50mcg | 2 inhalers | £152.22 | £338.26 £304.43 | |
| 250/50mcg | inhaler | £171.87 | £190.97 £171.87 | |
| 500/50mcg | 3 inhalers | £162.14 | £540.47 £486.42 Popular | |
| 500/50mcg | 2 inhalers | £177.50 | £394.43 £354.98 | |
| 500/50mcg | inhaler | £192.09 | £213.43 £192.09 |
What if your everyday breathing could be smoother, with fewer interruptions from wheeze or chest tightness? Advair Diskus is a prescribed inhaled medicine that combines two active ingredients to help manage chronic lung conditions.
The medicine belongs to a class that pairs an inhaled corticosteroid with a long‑acting bronchodilator. The active ingredients are fluticasone propionate and salmeterol xinafoate, delivered together in a Diskus inhaler for regular daily use. It is designed for long‑term maintenance, not for quick relief during a sudden attack.
Its purpose is to reduce airway inflammation and to keep the airways open so you can breathe more easily day by day. A healthcare professional will decide if this fixed-dose combination is appropriate for your asthma or COPD management plan and will tailor follow‑up to your response and any side effects.
Always read the official leaflet that comes with the inhaler and discuss any questions with your pharmacist or doctor if you are unsure about how this medicine fits your treatment regimen.
Advair Diskus is used as a maintenance controller medicine for long‑term management of asthma and chronic obstructive pulmonary disease (COPD). It is intended to reduce the frequency of symptoms and to prevent flare-ups when used regularly.
In asthma, it is prescribed for patients who require both an inhaled corticosteroid and a long‑acting bronchodilator to control ongoing symptoms such as coughing, wheeze, and breathlessness. It helps lower airway inflammation that can lead to tightening of the airways.
In COPD, Advair Diskus can help reduce day‑to‑day symptoms and the number of daytime and nighttime breathing problems. It is not a rescue inhaler and should not be used to treat sudden, severe breathing difficulties. If symptoms worsen rapidly, seek urgent medical help.
Your healthcare professional will determine whether Advair Diskus is appropriate for you based on your condition, history, and other medicines you may be taking. If you have questions about whether this medicine is right for you, check the official patient information leaflet or speak with a pharmacist or doctor.
Fluticasone propionate is an inhaled corticosteroid that reduces inflammation inside the airways. This helps decrease swelling and irritation that can trigger wheeze and breathlessness.
Salmeterol xinafoate is a long‑acting beta‑agonist (LABA) which relaxes the smooth muscles around the airways. This keeps the airways open for longer and makes it easier to breathe, especially during physical activity or symptom flares.
Together, these components provide ongoing control of symptoms rather than rapid relief. The combination targets both the inflammatory process and the constriction of airways, which is why adherence and regular use are important for effectiveness. If you have any concerns about how this mechanism applies to your condition, consult your healthcare professional or refer to the official leaflet for the product.
Advair Diskus is intended for regular, ongoing use as prescribed by a clinician. It should be used exactly as directed, and not as a rescue medicine for an acute asthma or COPD attack. If you have an acute attack, seek urgent medical assistance and use your prescribed rescue inhaler if available.
Dosage guidance is individualized. A typical approach in many cases is one inhalation of Advair Diskus twice daily, approximately 12 hours apart, but your doctor will determine the right dose for you and may adjust it over time. Do not change the dose without consulting your clinician.
Administration and technique are important. To use the Diskus correctly, follow the steps in the product leaflet or have your pharmacist demonstrate the method. After inhaling, rinse your mouth with water and spit it out to reduce the chance of throat irritation or oral thrush. Store the device with the mouthpiece closed and protect it from moisture and heat.
General timing and administration considerations include: taking Advair Diskus at the same times each day helps with consistency; avoid eating or drinking immediately before or after inhalation if advised by your clinician; do not double the dose if you miss one. If you miss a dose, follow the guidance given in the patient leaflet or contact your pharmacist for advice. For detailed steps and tips, check the official leaflet supplied with your product and ask your pharmacist to reinforce the technique during your next visit.
You should not use Advair Diskus if you have a known allergy to fluticasone propionate, salmeterol, or any other ingredients in the inhaler. A history of severe allergic reactions to medicines or inhaled components requires careful evaluation before use.
It is not intended for relief of an acute asthma attack or sudden breathing problems. If you need urgent relief, you should have a fast-acting inhaler as advised by your clinician.
People with certain conditions or infections affecting the lungs or systemic viral infections should discuss risk and benefit with a clinician before starting therapy. If you are unsure whether your medical history affects eligibility, check the official leaflets and speak with a healthcare professional.
Use of Advair Diskus may increase the risk of certain infections in the lungs, particularly in people with COPD. Contact your clinician if you develop a fever, persistent cough, or unusual sputum as these could indicate an infection.
Inhaled corticosteroids can affect growth in children, so clinicians monitor growth in paediatric patients and adjust therapy if needed. If you notice slower growth or other concerns, discuss them with your child’s doctor.
Oral thrush (a yeast infection in the mouth) and hoarseness are possible due to medication deposition in the throat. Rinsing the mouth after each use and using a spacer if advised by your clinician can help lower this risk. If throat irritation continues, speak with your pharmacist or doctor.
Tell your clinician about any symptoms such as chest pain, palpitations, tremor, or feeling unusually agitated or anxious, as these could reflect systemic effects of beta‑agonists in rare cases. If you have a history of heart rhythm problems or high blood pressure, your doctor may monitor you more closely while on therapy.
Common side effects include throat irritation, hoarseness, and coughing after inhalation. Some people may notice a stuffy or runny nose or an upper respiratory tract infection.
Less common effects can include headache, dizziness, or a white coating in the mouth or on the tongue, which may indicate oral thrush. Rinsing the mouth after use or using a spacer as advised can reduce this risk.
More rarely, some people may experience increased heart rate, tremor, or swelling of the ankles or feet. If you notice new or severe symptoms after starting Advair Diskus, contact a clinician for assessment.
If you experience signs of a serious allergic reaction—rash, swelling of the face or throat, or trouble breathing—seek urgent medical help. For any persistent or troubling side effects, speak with your pharmacist or doctor to review your treatment plan.
Tell your pharmacist about all medicines you take, including over‑the‑counter products and supplements. Some medicines can interact with Advair Diskus and affect breathing or increase side effects.
Concomitant use with non‑selective beta‑blockers or certain stimulant drugs may influence heart rate and blood pressure or the effect of the inhaled medicines. Your clinician will consider these risks when prescribing.
Some antifungal medications and certain antiviral drugs can alter the metabolism of inhaled corticosteroids, potentially increasing side effects. Do not start or stop medicines without medical advice, and always check with a pharmacist before combining therapies.
Avoid untreated ingestion of Advair Diskus with other inhaled steroids unless directed by a clinician. If you are unsure about interactions, check the official leaflet or speak to your healthcare professional.
Inhaled corticosteroids and long‑acting beta‑agonists may be used during pregnancy when clearly needed. Decisions are guided by the balance of benefits to the mother and potential risks to the fetus. Discuss all options with your obstetrician or midwife.
Breastfeeding while using Advair Diskus is a decision you should make with your clinician, as small amounts of the medication can pass into breast milk. Your clinician can help weigh potential benefits and risks for you and your baby.
If you become pregnant while using Advair Diskus, do not stop treatment abruptly unless advised by your clinician. Contact your healthcare professional to review the best plan for your situation.
Always check the official leaflet and speak with your doctor or pharmacist if you are pregnant, planning a pregnancy, or breastfeeding. They can help navigate safe use and alternatives if needed.
Can Advair Diskus start working right away, or should I expect gradual improvement? Inhaled medicines for chronic lung conditions typically show gradual benefit over days to weeks of regular use. If your symptoms worsen or you do not notice improvement after a few weeks, contact your clinician.
What should I do if I miss a dose? Missing a dose can reduce control of symptoms. Check your leaflet for guidance, and contact your pharmacist or doctor if you are unsure what to do. Do not double the dose to catch up without medical advice.
Is it safe to use Advair Diskus with my other inhalers or tablets? Tell your clinician about all medicines you take. Some combinations require adjustments or monitoring to avoid interactions or over‑medication of the airways.
How long will I need to use Advair Diskus? Your doctor will determine the duration based on your condition and response. Some people use it for long periods as part of ongoing maintenance, while others may adjust therapy over time.
What if my symptoms get worse or I have a severe flare‑up? Seek urgent medical help if you experience a sudden and serious worsening of breathlessness, chest tightness, or confusion. Your rescue plan and inhaler usage should be discussed with a clinician beforehand.
Can I stop using Advair Diskus suddenly? Do not stop or change therapy abruptly without medical advice. Stopping abruptly can cause a rebound worsening of symptoms or flare‑ups.
Is it safe to use Advair Diskus during pregnancy or while breastfeeding? This should be discussed with your obstetrician or midwife. The clinician will consider the benefits to the mother against potential risks to the baby and may propose a plan tailored to you.
How soon should I contact a doctor about side effects or concerns? If you notice persistent throat irritation, mouth infections, unusual weight changes, or any new or concerning symptoms, arrange a review with your clinician or pharmacist promptly.
Always refer to the official patient information leaflet that accompanies Advair Diskus for detailed instructions, dosing, and safety information. It provides a section‑by‑section guide to the medicine and its proper use.
Your pharmacist is a good source of practical advice on inhaler technique, storage, and how to manage minor side effects. Do not hesitate to ask for a demonstration of how to use the Diskus correctly and to check your technique at your next visit.
For broader information, discuss your treatment plan with your GP, respiratory specialist, or other healthcare professionals involved in your care. If you have questions about how Advair Diskus fits with your medical history, personal circumstances, or other medications, they can provide tailored guidance and reassurance.
In the United Kingdom, you may also consult the official leaflets provided by the manufacturer and the Medicines and Healthcare products Regulatory Agency (MHRA) resources as part of your informed decision‑making. If anything is unclear, check with your clinician or pharmacist before continuing.
14–21 days. Free from £149.79 .
5–9 days. £22.47
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
